Podimetrics is a virtual care management company dedicated to preventing costly and deadly diabetic amputations.
Podimetrics is on a mission to prevent foot amputations in diabetic patients.
Podimetrics was founded in 2011 by a physician and engineers from MIT and Harvard. The company is headquartered in Somerville, Massachusetts.
Podimetrics developed the FDA-cleared SmartMat™ and integrated clinical care services that can help save the limbs and lives of complex patients with diabetes.
Podimetrics, by combining cutting-edge technology with best-in-class clinical care services, earns high engagement rates from patients and allows clinicians to save limbs, lives, and money — all while keeping vulnerable populations healthy in their own homes.
The SmartMat, which also has the Seal of Approval from the American Podiatric Medical Association, has already been used by thousands of patients through partnerships with leading risk-based healthcare providers and regional and national health plans, such as the Veterans Health Administration.
Podimetrics backed by D1 Capital Partners, Polaris Partners, Norwich Ventures, Scientific Health Development, Rock Health, Medtech Convergence Fund, and others. The company raised $45M in Series C round on Mar 24, 2022. This brings Podimetrics' total funding to $73.3M to date.